Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Cellular Neuroscience|July 6, 2026
SMΝΔ7 mice show breathing and airflow defects with significant pathology of respiratory and oral tract tissuesRoxanne Muchow, Michelle Woolridge, Catherine L Smith, et al.
Brain Research|May 12, 2012
G protein-coupled receptor oligomerization and brain integration: focus on adenosinergic transmissionFrancisco Ciruela, Víctor Fernández-Dueñas, Javier Llorente, et al.
Molecular Pharmacology|May 30, 2013
Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neuronsJavier Llorente, Sarah Withey, Guadalupe Rivero, et al.
Human Molecular Genetics|July 9, 2025
Novel neurofilament light (Nefl) E397K mouse models of Charcot-Marie-tooth type 2E (CMT2E) present early and chronic axonal neuropathyDennis O Pérez-López, Audrey A Shively, F Javier Llorente Torres, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Novel neurofilament light (Nefl) E397K mouse models of Charcot-Marie-Tooth type 2E (CMT2E) present early and chronic axonal neuropathyDennis O Pérez-López, Audrey A Shively, F Javier Llorente Torres, et al.
Molecular Pharmacology|May 4, 2012
Endomorphin-2: a biased agonist at the μ-opioid receptorGuadalupe Rivero, Javier Llorente, Jamie McPherson, et al.
Molecular Pharmacology|July 22, 2010
μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalizationJamie McPherson, Guadalupe Rivero, Myma Baptist, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 31, 2014
Coassembly and coupling of SK2 channels and mGlu5 receptorsGloria García-Negredo, David Soto, Javier Llorente, et al.
ACS Chemical Neuroscience|December 21, 2020
Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML)Ivo E Sampaio-Dias, José E Rodríguez-Borges, Víctor Yáñez-Pérez, et al.
Experimental Neurology|October 26, 2024
Ighmbp2 mutations and disease pathology: Defining differences that differentiate SMARD1 and CMT2SSara M Ricardez Hernandez, Bassil Ahmed, Yaser Al Rawi, et al.
Pageof 3